PaxMedica Ownership 2024 | Who Owns PaxMedica Now?

OverviewFinancials Chart

Institutional Ownership

2.02%

Insider Ownership

12.60%

Retail Ownership

85.38%

Institutional Holders

13.00

PaxMedica Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-4	-100.00%	-	Dec 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-500	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-35	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-21,900	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-54,959	-100.00%	-	Dec 31, 2023
CLEARSTEAD ADVISORS, LLC	-	-	-	-38,156	-100.00%	-	Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-97,100	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-30,781	-100.00%	-	Dec 31, 2023
HRT FINANCIAL LP	-	-	-	-10,773	-100.00%	-	Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-7,885	-100.00%	-	Dec 31, 2023
UBS GROUP AG	-	-	-	-1,098	-100.00%	-	Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-2,000	-100.00%	-	Dec 31, 2023

PaxMedica's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-4	-100.00%	-	Dec 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-500	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-35	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-21,900	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-54,959	-100.00%	-	Dec 31, 2023
CLEARSTEAD ADVISORS, LLC	-	-	-	-38,156	-100.00%	-	Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-97,100	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-30,781	-100.00%	-	Dec 31, 2023
HRT FINANCIAL LP	-	-	-	-10,773	-100.00%	-	Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-7,885	-100.00%	-	Dec 31, 2023
UBS GROUP AG	-	-	-	-1,098	-100.00%	-	Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-2,000	-100.00%	-	Dec 31, 2023

The largest PaxMedica shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of PaxMedica (PXMD), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-4	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-35	-100.00%	-	Dec 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-500	-100.00%	-	Dec 31, 2023
UBS GROUP AG	-	-	-	-1,098	-100.00%	-	Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-2,000	-100.00%	-	Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-7,885	-100.00%	-	Dec 31, 2023
HRT FINANCIAL LP	-	-	-	-10,773	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-21,900	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-30,781	-100.00%	-	Dec 31, 2023
CLEARSTEAD ADVISORS, LLC	-	-	-	-38,156	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-54,959	-100.00%	-	Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-97,100	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, PaxMedica's largest institutional buyer is JPMORGAN CHASE & CO. The company purchased -4.00 stocks of PXMD, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-97,100	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-54,959	-100.00%	-	Dec 31, 2023
CLEARSTEAD ADVISORS, LLC	-	-	-	-38,156	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-30,781	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-21,900	-100.00%	-	Dec 31, 2023
HRT FINANCIAL LP	-	-	-	-10,773	-100.00%	-	Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-7,885	-100.00%	-	Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-2,000	-100.00%	-	Dec 31, 2023
UBS GROUP AG	-	-	-	-1,098	-100.00%	-	Dec 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-500	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-35	-100.00%	-	Dec 31, 2023
JPMORGAN CHASE & CO	-	-	-	-4	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, PaxMedica's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -97.10K shares of PXMD, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-97,100	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-54,959	-100.00%	-	Dec 31, 2023
CLEARSTEAD ADVISORS, LLC	-	-	-	-38,156	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-30,781	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-21,900	-100.00%	-	Dec 31, 2023
HRT FINANCIAL LP	-	-	-	-10,773	-100.00%	-	Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-7,885	-100.00%	-	Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-2,000	-100.00%	-	Dec 31, 2023
UBS GROUP AG	-	-	-	-1,098	-100.00%	-	Dec 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-500	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-35	-100.00%	-	Dec 31, 2023
JPMORGAN CHASE & CO	-	-	-	-4	-100.00%	-	Dec 31, 2023

PaxMedica's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -97.10K shares, valued at -, as of undefined.

PaxMedica Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	30,332	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	54,959	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	1,783	-1	-0.06%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	3,235	-3,235	-50.00%	Mar 31, 2024

PaxMedica's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 30.33K shares, compromising 0.00% of its total assets.

PaxMedica Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 23	13	62.50%
30 Jun, 23	8	-20.00%
31 Mar, 23	10	42.86%
31 Dec, 22	7	40.00%
30 Sep, 22	5	-

As of 30 Sep 23, 13 institutions are holding PaxMedica's shares, representing an increase of 62.50% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 23	296,225	40.46%
30 Jun, 23	210,894	30.89%
31 Mar, 23	161,129	86.38%
31 Dec, 22	86,452	56.60%
30 Sep, 22	55,207	-

PaxMedica (PXMD) has 296.23K shares outstanding as of 30 Sep 23, up 40.46% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 23	2.02%	72.51%
30 Jun, 23	1.67%	102.66%
31 Mar, 23	1.27%	130.35%
31 Dec, 22	0.99%	273.33%
30 Sep, 22	0.60%	-

As of 30 Sep 23, PaxMedica is held by 2.02% institutional shareholders, representing a 72.51% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 23	7	75.00%
30 Jun, 23	4	-20.00%
31 Mar, 23	5	-16.67%
31 Dec, 22	6	20.00%
30 Sep, 22	5	-

7 institutional shareholders have increased their position in PXMD stock as of 30 Sep 23 compared to 4 in the previous quarter (a 75.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 23	1	-
30 Jun, 23	1	-66.67%
31 Mar, 23	3	200.00%
31 Dec, 22	1	-
30 Sep, 22	-	-

1 institutional shareholders have reduced their position in PXMD stock as of 30 Sep 23 compared to 1 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 23	13	62.50%	296,225	40.46%	2.02%	72.51%	7	75.00%	1	-
30 Jun, 23	8	-20.00%	210,894	30.89%	1.67%	102.66%	4	-20.00%	1	-66.67%
31 Mar, 23	10	42.86%	161,129	86.38%	1.27%	130.35%	5	-16.67%	3	200.00%
31 Dec, 22	7	40.00%	86,452	56.60%	0.99%	273.33%	6	20.00%	1	-
30 Sep, 22	5	-	55,207	-	0.60%	-	5	-	-	-

PaxMedica Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 31, 2024	Rome Zachary	director	-	S-Sale	Sell	811	$0.48	$389.28	15,148
Jan 31, 2024	LaRochelle Karen	director	-	S-Sale	Sell	78	$0.48	$37.44	2,829
Jan 31, 2024	Coelho John F	director	-	S-Sale	Sell	27	$0.48	$12.96	4,615
Jan 31, 2024	Weisman Howard J.	director, officer	Chief Executive Officer	S-Sale	Sell	372	$0.47	$174.84	37,675
Nov 29, 2023	Coelho John F	director	-	S-Sale	Sell	12	$1.02	$12.30	4,642
Nov 29, 2023	Weisman Howard J.	director, officer	Chairman and CEO	S-Sale	Sell	162	$1.03	$166.24	38,047
Nov 29, 2023	Derby Michael	10 percent owner	-	S-Sale	Sell	185	$1.03	$189.88	25,650
Nov 29, 2023	LaRochelle Karen	director	-	S-Sale	Sell	35	$1.03	$35.93	2,907
Nov 29, 2023	Rome Zachary	director	-	S-Sale	Sell	359	$1.03	$369.88	15,959

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 14, 2024	Weisman Howard J.	director, officer	Chief Executive Officer	F-InKind	Sell	2,927	$0.69	$2.02K	34,748
Mar 14, 2024	Sheldon Stephen	officer	CFO and COO	F-InKind	Sell	3,356	$0.69	$2.32K	10,137
Mar 14, 2024	Rome Zachary	director	-	F-InKind	Sell	4,904	$0.69	$3.38K	10,244
Mar 14, 2024	LaRochelle Karen	director	-	F-InKind	Sell	604	$0.69	$416.76	2,225
Mar 14, 2024	Hough David W.	officer	Chief Medical Officer	F-InKind	Sell	1,452	$0.69	$1.00K	5,905
Mar 14, 2024	Coelho John F	director	-	F-InKind	Sell	207	$0.69	$142.83	4,408
Mar 14, 2024	CASAMENTO CHARLES J	director	-	F-InKind	Sell	992	$0.69	$684.48	2,386
Feb 23, 2024	Hough David W.	officer	Chief Medical Officer	F-InKind	Sell	291	$0.66	$191.77	7,357
Feb 23, 2024	Sheldon Stephen	officer	CFO and COO	F-InKind	Sell	243	$0.66	$160.14	13,493
Jan 31, 2024	Rome Zachary	director	-	S-Sale	Sell	811	$0.48	$389.28	15,148
Jan 31, 2024	LaRochelle Karen	director	-	S-Sale	Sell	78	$0.48	$37.44	2,829
Jan 31, 2024	Coelho John F	director	-	S-Sale	Sell	27	$0.48	$12.96	4,615
Jan 31, 2024	CASAMENTO CHARLES J	director	-	F-InKind	Sell	97	$0.76	$73.72	3,378
Jan 31, 2024	Weisman Howard J.	director, officer	Chief Executive Officer	S-Sale	Sell	372	$0.47	$174.84	37,675
Nov 29, 2023	Coelho John F	director	-	S-Sale	Sell	12	$1.02	$12.30	4,642
Nov 29, 2023	Weisman Howard J.	director, officer	Chairman and CEO	S-Sale	Sell	162	$1.03	$166.24	38,047
Nov 29, 2023	Derby Michael	10 percent owner	-	S-Sale	Sell	185	$1.03	$189.88	25,650
Nov 29, 2023	LaRochelle Karen	director	-	S-Sale	Sell	35	$1.03	$35.93	2,907
Nov 29, 2023	Rome Zachary	director	-	S-Sale	Sell	359	$1.03	$369.88	15,959
Nov 22, 2023	Sheldon Stephen	officer	CFO and COO	F-InKind	Sell	971	$1.75	$1.70K	13,736

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 14, 2024	Weisman Howard J.	director, officer	Chief Executive Officer	F-InKind	Sell	2,927	$0.69	$2.02K	34,748
Mar 14, 2024	Sheldon Stephen	officer	CFO and COO	F-InKind	Sell	3,356	$0.69	$2.32K	10,137
Mar 14, 2024	Rome Zachary	director	-	F-InKind	Sell	4,904	$0.69	$3.38K	10,244
Mar 14, 2024	LaRochelle Karen	director	-	F-InKind	Sell	604	$0.69	$416.76	2,225
Mar 14, 2024	Hough David W.	officer	Chief Medical Officer	F-InKind	Sell	1,452	$0.69	$1.00K	5,905
Mar 14, 2024	Coelho John F	director	-	F-InKind	Sell	207	$0.69	$142.83	4,408
Mar 14, 2024	CASAMENTO CHARLES J	director	-	F-InKind	Sell	992	$0.69	$684.48	2,386
Feb 23, 2024	Hough David W.	officer	Chief Medical Officer	F-InKind	Sell	291	$0.66	$191.77	7,357
Feb 23, 2024	Sheldon Stephen	officer	CFO and COO	F-InKind	Sell	243	$0.66	$160.14	13,493
Jan 31, 2024	Rome Zachary	director	-	S-Sale	Sell	811	$0.48	$389.28	15,148
Jan 31, 2024	LaRochelle Karen	director	-	S-Sale	Sell	78	$0.48	$37.44	2,829
Jan 31, 2024	Coelho John F	director	-	S-Sale	Sell	27	$0.48	$12.96	4,615
Jan 31, 2024	CASAMENTO CHARLES J	director	-	F-InKind	Sell	97	$0.76	$73.72	3,378
Jan 31, 2024	Weisman Howard J.	director, officer	Chief Executive Officer	S-Sale	Sell	372	$0.47	$174.84	37,675
Nov 29, 2023	Coelho John F	director	-	S-Sale	Sell	12	$1.02	$12.30	4,642
Nov 29, 2023	Weisman Howard J.	director, officer	Chairman and CEO	S-Sale	Sell	162	$1.03	$166.24	38,047
Nov 29, 2023	Derby Michael	10 percent owner	-	S-Sale	Sell	185	$1.03	$189.88	25,650
Nov 29, 2023	LaRochelle Karen	director	-	S-Sale	Sell	35	$1.03	$35.93	2,907
Nov 29, 2023	Rome Zachary	director	-	S-Sale	Sell	359	$1.03	$369.88	15,959
Nov 22, 2023	Sheldon Stephen	officer	CFO and COO	F-InKind	Sell	971	$1.75	$1.70K	13,736

The last insider sell of PaxMedica's stock was made by Weisman Howard J. on Mar 14 2024, selling 2,927 shares at $0.69 per share (valued at $2.02K).

PaxMedica Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	14	-
Q4 2023	1	12	8.33%
Q3 2023	-	20	-
Q2 2023	7	7	100.00%
Q1 2023	-	22	-
Q4 2022	2	-	-
Q3 2022	2	12	16.67%
Q4 2020	-	2	-

0 total buy trades, and 14 total sell trades (buy/sell ratio of 0.00%) were made by PaxMedica's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	4	-
Q4 2023	-	10	-
Q3 2023	-	14	-
Q2 2023	-	-	-
Q1 2023	-	22	-
Q4 2022	-	-	-
Q3 2022	2	-	-
Q4 2020	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of PaxMedica's stocks.

PaxMedica Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
BDRX	Biodexa Pharmaceuticals Plc
BWV	Onconetix, Inc.
KPRX	Kiora Pharmaceuticals, Inc.
REVB	Revelation Biosciences, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
HILS	Tharimmune, Inc.
VRAX	Virax Biolabs Group Limited
ALLR	Allarity Therapeutics, Inc.
IMMX	Immix Biopharma, Inc.
UNCY	Unicycive Therapeutics, Inc.
CDIO	Cardio Diagnostics Holdings, Inc.
PALI	Palisade Bio, Inc.

PXMD Ownership FAQ

Who Owns PaxMedica?

PaxMedica is owned by institutional shareholders (2.02%), insiders (12.60%), and public (85.38%). The largest institutional shareholder of PaxMedica is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of PaxMedica?

PaxMedica's major institutional shareholders are JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, STATE STREET CORP, and VANGUARD GROUP INC. The top five shareholders own together 0% of the company's share outstanding.

How many PaxMedica shareholders are there?

As of Sep 2023, there are 13 institutional shareholders of PaxMedica.

What percentage of PaxMedica is owned by JPMORGAN CHASE & CO?

JPMORGAN CHASE & CO owns 0 shares of PaxMedica, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).

What percentage of PaxMedica is owned by BANK OF AMERICA CORP /DE/?

As of Dec 2023, BANK OF AMERICA CORP /DE/ holds 0 shares of PaxMedica (PXMD), compromising 0% of the company, valued at $0.

What percentage of PaxMedica is owned by WELLS FARGO & COMPANY/MN?

WELLS FARGO & COMPANY/MN is the third largest holder of PaxMedica. The company owns 0 of the company's shares outstanding (worth $0).